Latest Revenue Growth News

EML Payments has affirmed its FY26 underlying EBITDA guidance of A$58-63 million following a solid Q1 trading update, underpinned by a growing new program pipeline and operational efficiencies.

OMG Group has inked a five-year exclusive distribution agreement with SANDAI, a premium Japanese matcha producer, positioning itself to capture significant growth in Australia’s expanding matcha market.

Cyclopharm Limited reaffirms its ambitious target of 250–300 US Technegas installations by late 2026, driven by FDA approval, CMS reimbursement, and a growing pipeline of healthcare sites. The company reports record half-year revenue growth, signaling strong momentum in the expanding lung imaging market.

Nuix Limited’s 2025 AGM revealed steady ACV growth, a leadership transition, and a strategic push centered on its Nuix Neo platform to fuel future expansion.

Lark Distilling Co. Ltd reported a 12% increase in FY25 revenue to $15.6 million, bolstered by a strategic partnership with Seppeltsfield Wines and a successful brand restage. The company also announced a leadership change with a new CEO set to take the helm in January 2026.

Rent.com.au has seen option holders exercise over $4 million early, injecting significant growth capital and accelerating its path to profitability.

Saunders International reported a challenging FY2025 with profit declines amid operational headwinds but strengthened its Water sector presence through the Aqua Metro acquisition. The company projects a stronger FY2026 backed by a record $4 billion pipeline and improved margins.

AVADA Group’s CEO Donald Montgomery outlined a year of operational consolidation and transformation at the 2025 AGM, reporting significant safety improvements and early signs of revenue growth in 2026 despite ongoing market challenges.

AVADA Group reported a 10.5% revenue decline in FY2025 amid operational consolidation and leadership changes, while conducting a strategic review of its New Zealand operations. Despite setbacks, the company remains cautiously optimistic about future growth.

Clover Corporation Limited reported a standout FY25 with robust revenue growth and a sharp rise in profitability, underpinned by strategic market expansion and product innovation. The company’s strengthened balance sheet and optimistic FY26 outlook signal continued momentum.

Regis Healthcare reported robust FY25 financial results and outlined ambitious expansion plans targeting 10,000 beds by FY28, while urging urgent government reforms to address the sector’s undersupply of quality aged care.

QuickFee Limited reports a pivotal FY25 with strong revenue growth and positive underlying profitability, alongside a strategic sale of its US Pay Now business and a proposed capital return to shareholders.